![]() |
市場調查報告書
商品編碼
1380460
2023-2030 年全球人工智慧 (AI) 心理健康市場Global Artificial Intelligence (AI) in Mental Health Market 2023-2030 |
預計在預測期(2023-2030年),全球心理健康市場人工智慧(AI)將以38.1%的CAGR成長。全球自殺案件數量不斷增加以及人們對精神疾病的認知不斷提高是市場的重要促進因素根據世界衛生組織(WTO)2023年8月發布的報告,每年有超過70萬人因自殺而死亡。在高收入國家,自殺與精神障礙(特別是憂鬱症和酗酒障礙)以及先前的自殺企圖之間的聯繫已得到充分證實,許多自殺都是在危機時刻衝動發生的,導致應對生活壓力的能力崩潰,例如財務問題、關係破裂或慢性疼痛和疾病。因此,市場參與者正在關注整個醫療保健領域基於人工智慧的先進心理健康解決方案,例如,2020 年 6 月,Biobeat 被列入 MediCompare「十大心理健康醫療科技新創公司」。 Biobeats 設備可用於幫助精神保健提供者監測患者從危機到康復的過程。
全球心理健康市場人工智慧(AI)按技術、應用和組件進行細分。根據技術,市場細分為機器學習、深度學習和自然語言處理(NLP)。根據應用程式,市場分為對話式介面和患者行為模式識別。此外,根據組件,市場分為軟體即服務(SaaS)和硬體。在所有自然語言處理(NLP)細分市場中,預計將佔據相當大的市場佔有率
因為 NLP 在精神病學中至關重要,基於語言的缺陷是憂鬱症、行為障礙、自閉症譜系障礙、人格障礙和精神分裂症的常見症狀。
Title: Global Artificial Intelligence (AI) in Mental Health Market Size, Share & Trends Analysis Report by Technology (Machine Learning and Deep Learning, Natural Language Processing (NLP)), by Application (Conversational Interfaces, Patient Behavioral Pattern Recognition), and by Component (Software-as-a-Service (SaaS), Hardware),Forecast Period (2023-2030).
The global artificial Intelligence (AI) in mental health market is anticipated to grow at a CAGR of 38.1% during the Forecast Period (2023-2030). Globally increasing number of suicide cases and growing awareness of mental disorder are significant driving factors of the market According to a report published by the World Health Organization (WTO) on August 2023, more than 7,00,000 people die due to suicide every year. The link between suicide and mental disorders (in particular, depression and alcohol use disorders) and a previous suicide attempt is well established in high-income countries, many suicides happen impulsively in moments of crisis with a breakdown in the ability to deal with life stresses, such as financial problems, relationship break-up or chronic pain and illness. Hence, the market players are focusing on advanced AI-based mental health solutions across the healthcare sector for instance, In June 2020, Biobeat was mentioned in the MediCompare "Top 10 Mental Health Medtech Startups". Biobeats devices can be utilized to help aid mental healthcare providers in monitoring their patients from crisis to recovery.
The global artificial Intelligence (AI) in mental health market is segmented on the technology, application, and component. Based on the technology, the market is sub-segmented into machine learning deep learning, and natural language processing (NLP). Based on the application, the market is sub-segmented into conversational interfaces and patient behavioral pattern recognition. Further, on the basis of components, the market is sub-segmented into software-as-a-service (SaaS) and hardware. Among all the natural language processing (NLP) sub-segments is anticipated to hold a considerable share of the market
because NLP is essential in psychiatry language-based deficits are common symptoms of depression, behavioral disorder, ASD, personality disorder, and schizophrenia.
Among the vertical, the machine learning and deep learning sub-segment is expected to hold a considerable share of the global artificial Intelligence (AI) in mental health. According to the National Library of Medicine, ML systems automatically learn models from data to make better decisions. As such, they are part of a major subfield of artificial intelligence (AI). There are three main approaches to learning from data such as supervised, unsupervised, and reinforcement learning, especially web and smartphone apps, are incorporating AI to enhance mental health care for Instance, in January 2023, Ginger.io, Inc. On-demand, self-guided activities through the Headspace app to build proactive skills and enhance everyday wellbeing. Employees can access more than 1,000 hours of mindfulness content from evidence-based guided meditations, eyes-open exercises like mindful walks and runs, breathing and wind-down exercises, focus music, sleep content, and more.
The global artificial Intelligence (AI) in the mental health market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, due to the well-established healthcare infrastructure, availability of high-quality professional assistance, and a strong focus on mental health awareness and treatments.
Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing investment flow in AI across Asian countries. Expansion of global market players in the Asian markets including China, and India, and in development such as IT infrastructure innovation and development, and also the entrepreneurial companies concentrating on AI-based technologies is driving the market according to The Hong Kong Polytechnic University, The mental health research entre (MHRC) strives to triangulate basic science, clinical intervention and social policy in our core research so that we can comprehensively explore the mechanisms behind mental illnesses and the practical measures for treating them, to make an impact on individual well-being and the social policy in Hong Kong and beyond.
The major companies serving the global artificial Intelligence (AI) in the mental health market include: Lyra Health, Inc., Marigold Health, New Life Counseling, Mental Health LLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Lyra Health acquired ICAS World to expand its mental health care services globally with this acquisition, lyra, and ICAS are setting a new standard for global mental health care. Companies around the world will now have a single source for innovative, evidence-based, culturally responsive mental health benefits for employees and their families